Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 11/20 | 0.49 |
| ▸ | SCTR | P47872 | 1/20 | 0.49 |
| ▸ | CALCR | P30988 | 4/20 | 0.47 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | GCGR | P47871 | 1/20 | 0.47 |
| ▸ | GRPR | P30550 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29387542 | 0.99 | GLP1R (0.49) | GLP1RSCTRCALCRCRHR1CRHR2 | |
| SCHEMBL30525424 | 0.95 | GRPR (0.47) | GLP1RSCTRCALCRCRHR1CRHR2 | |
| SCHEMBL30930541 | 0.89 | GLP1R (0.54) | GLP1RSCTRGCGR | |
| SCHEMBL30974400 | 0.88 | GLP1R (0.49) | GLP1RSCTRGRPR | |
| SCHEMBL30512529 | 0.87 | GLP1R (0.48) | GLP1RSCTRCALCRCRHR1CRHR2 | |
| SCHEMBL30436887 | 0.87 | CALCR (0.55) | GLP1RSCTRCALCRCRHR1CRHR2 | |
| SCHEMBL29680082 | 0.86 | GLP1R (0.51) | GLP1RSCTRCALCRCRHR1CRHR2 | |
| SCHEMBL29798786 | 0.86 | GLP1R (0.46) | GLP1RSCTRCALCRGCGRGRPR | |
| SCHEMBL30262188 | 0.86 | GLP1R (0.59) | GLP1RSCTRGCGR | |
| SCHEMBL30974246 | 0.85 | BACE1 (0.47) | GLP1RSCTRGRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12364755-B2 | Method for obtaining globally activated monocytes | TRANSIMMUNE AG (DE) | 2025-07-22 | — | — | US | disclosed |
| EP-3741843-B1 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | TRANSIMMUNE AG (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-20240093151-A1 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | YALE UNIVERSITY | 2024-03-21 | — | — | US | disclosed |
| EP-3954377-B1 | METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES | TRANSIMMUNE AG (DE) | 2023-09-06 | — | — | EP | disclosed |
| EP-4159222-A1 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | Transimmune AG (DE) | 2023-04-05 | — | — | EP | disclosed |
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |
| US-20220280562-A1 | METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES | TRANSIMMUNE AG (DE) | 2022-09-08 | — | — | US | disclosed |
| EP-3316896-B1 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | TRANSIMMUNE AG (DE) | 2022-09-07 | — | — | EP | disclosed |
| US-20220259556-A1 | METHOD FOR OBTAINING IMMUNO-SUPPRESSIVE DENDRITIC CELLS | TRANSIMMUNE AG (DE) | 2022-08-18 | — | — | US | disclosed |
| CN-114410581-A | Method for obtaining immunosuppressive dendritic cells | 特兰西穆内有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-106604988-B | Method for obtaining globally activated monocytes | 特兰西穆内有限公司 | 2022-04-19 | — | — | CN | disclosed |
| US-20220112462-A1 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | TRANSIMMUNE AG (DE) | 2022-04-14 | — | — | US | disclosed |
| EP-3954377-A1 | METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES | Transimmune AG (DE) | 2022-02-16 | — | — | EP | disclosed |